Pediatric Disease Registry in Essential Thrombocythaemia (ET)
Status
Completed
Conditions
Essential Thrombocythemia (ET)
Details and patient eligibility
About
The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.
Enrollment
60 patients
Sex
All
Ages
6 to 17 years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- 6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance
Exclusion criteria
- Interventional clinical study participation
Trial contacts and locations
32
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems